Study supports use of LVADs (left ventricular assist devices) before heart transplant
This article was originally published in Clinica
Heart transplant candidates who receive implantable mechanical heart pumps until donor hearts become available have a better chance of survival and lower post-transplant death rates than those relying on medication. This was the conclusion of a US study published in the Journal of the American College of Cardiology (April 17).
You may also be interested in...
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.
Mylan’s full year 2019 earnings report was its last as an independent company, so the focus was on the coming merger with Pfizer’s Upjohn and growth prospects for the new company, Viatris.
Colgate Zero toothpastes and mouthwashes promote what’s missing; Tom’s of Maine natural personal care expands with prebiotic toothpaste, deodorant and hand soap; Gaia adds hemp to its herbs; and Church & Dwight goes environmentally friendly with VitaFusion Goodness supplements, adds CBD versions to line, too.